Canagliflozin Audit EASD Berlin 2018 - Abstract

2 year metabolic outcomes in the ABCD nationwide canagliflozin audit Author Block:

A. Puttanna¹, M. Yadagiri¹, P. Sen Gupta¹, I. Gallen², A. Bickerton³, S. Phillips⁴, A. Evans⁴, D. Sennik⁵, R. Ryder¹

¹Diabetes and Endocrinology, Sandwell and West Birmingham NHS Trust, Birmingham, UK

²Diabetes and Endocrinology, Royal Berkshire Hospitals NHS Trust, Berkshire, UK

³Diabetes and Endocrinology, Yeovil District Hospital NHS Trust, Yeovil, UK

⁴Diabetes and Endocrinology, Cheltenham General Hospital, Cheltenham, UK

⁵Diabetes and Endocrinology, Princess Alexandra Hospital, Harlow, UK.